Four ways we move a product forward.

Partnerships

Strategic Partnerships

We connect pharmaceutical companies, technology owners, manufacturers and commercial partners, turning shared capabilities and market demand into practical partnerships.

• Strategic alliances

  Shared goals and complementary capabilities, built for long-term growth.

• Products and technologies

  Differentiated products and technologies for licensing and development.

• Manufacturing collaboration

  Product owners matched with development and manufacturing partners.

• Market entry

  Partner alignment, regulatory pathways and entry planning by territory.

Discuss a partnership

Licensing

Licensing & Commercialization

Licensing models shaped by each product's maturity, target markets, responsibilities and commercial goals.

• In-licensing

  Products and technologies from partners, for our portfolio or joint development.

• Out-licensing

  Partners and routes to market for products in our network.

• Co-development

  Partners whose technical, regulatory and commercial strengths complement each other.

Explore licensing

Technology Transfer

Technology Transfer

We connect technology owners with qualified manufacturers and coordinate the transfer, for complex generics and specialized products.

• 01

  Assess

  Review the process and evaluate manufacturing partners.

• 02

  Plan

  Set scope, documents, timelines and milestones.

• 03

  Coordinate

  Manage document exchange between authorized parties.

• 04

  Scale up

  Plan scale-up, exhibit batches and validation.

• 05

  Align

  Keep the transfer in line with dossier requirements.

• 06

  Get ready

  Coordinate toward commercial supply.

Scientific, manufacturing, quality and validation work is performed by qualified, authorized partners.

Plan a transfer

Regulatory

Regulatory Services

We identify registration pathways and coordinate requirements with the right regulatory and technical partners in each market.

• API registration

  Documentation and requirements for active pharmaceutical ingredients, by market.

• Product registration

  Dossier coordination, review and submission through the relevant partners.

• Medical devices

  Registration requirements and documentation for devices in selected markets.

• Regulatory strategy

  Pathway assessment and planning for market authorization in each territory.

Approval and authorization remain the decision of the relevant authorities.

Discuss a registration